Skip to main content
OpenTrials

Clinical trial condition

Acquired Thrombotic Thrombocytopenic Purpura

Explore clinical trials studying Acquired Thrombotic Thrombocytopenic Purpura. Study availability and eligibility vary by location and protocol.

7 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Acquired Thrombotic Thrombocytopenic Purpura trial results

Completed

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

NCT02553317

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Investigator Site Birmingham, Alabama, United States
  • Investigator Site Los Angeles, California, United States
  • Investigator Site Atlanta, Georgia, United States
  • Investigator Site Boston, Massachusetts, United States
View all 101 locations
View Trial Details
Completed

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

NCT01151423

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Investigator Site Los Angeles, California, United States
  • Investigator Site Washington D.C., District of Columbia, United States
  • Investigator Site Atlanta, Georgia, United States
  • Investigator Site St Louis, Missouri, United States
View all 51 locations
View Trial Details
Completed

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

NCT02878603

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Investigator site St Louis, Missouri, United States
  • Investigator site Valhalla, New York, United States
  • Investigator Site Durham, North Carolina, United States
  • Investigator Site Columbus, Ohio, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura

NCT05046717

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Centro Hospitalar e Universitario de Coimbra Coimbra, Coimbra District, Portugal
  • Complejo Hospitalario Universitario A Coruña A Coruña, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital Clínico San Carlos Madrid, Spain
View Trial Details

Related conditions